Digital Look

Welcome to Digital Look++,
you are not logged in

Merck & Co. Inc. (MRK)

$ 99.18

Merck increases antibiotic offering with $9.5bn ...	09-Dec-2014	Telegraph
Reckitt Benckiser bows out of race for Merck's c...	01-May-2014	Telegraph
Patents Ending, Eli Lilly Chases New Drugs	01-Oct-2010	New York Times
Another Loss for Pfizer in Drug Suits	25-Nov-2009	New York Times
Bristol-Myers, partner AstraZeneca get EU approv...	06-Oct-2009	Chicago Tribune
Abbott buys Belgian drug unit for $6.6B	29-Sep-2009	Wall Street Journal
Abbott in $6.6 Billion Deal for Drug Unit	29-Sep-2009	New York Times
Jury Deadlock Ends a Trial Over Merck’s Bone Drug	13-Sep-2009	New York Times
Merck & Co. shareholders OK $41.1 billion acquis...	08-Aug-2009	Chicago Tribune
Schering and Merck Are Settling Vytorin Suits	06-Aug-2009	New York Times
Merck, insurance plans settle Vioxx suits for $80M	04-Aug-2009	USA Today
Merck Selling Stake in Animal Venture	31-Jul-2009	New York Times
Sanofi and Merck Announce $4 Billion Merial Sale	31-Jul-2009	New York Times
Wyeth shareholders OK Pfizer buying company	21-Jul-2009	Wall Street Journal
AstraZeneca, Merck team up on cancer treatment	02-Jun-2009	LA Times
Pfizer Profit Dips on Ease in Demand for Lipitor	29-Apr-2009	New York Times
Merck Quarterly Profit Plunges 57%	21-Apr-2009	New York Times
Glaxo to Acquire Lab for $2.9 Billion	20-Apr-2009	New York Times
Glaxo and Pfizer Join Forces to Develop and Mark...	17-Apr-2009	New York Times
Biotech deals involve 3 firms in Bay Area	13-Mar-2009	LA Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.